Skip to main content
Log in

The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid

  • Research Articles
  • Drug Actions
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the relationship between hepatotoxicity, levels of glucuronide conjugates of valproic acid (VPA), and the toxic metabolites of VPA (4-ene VPA and 2,4-diene VPA). We also examined whether hepatotoxicity could be predicted by the urinary excretion levels of VPA and its toxic metabolites. VPA was administrated orally in rats in amounts ranging from 20 mg/kg to 500 mg/kg. Free and total (free plus glucuronide conjugated) VPA, 4-ene VPA, and 2,4-diene VPA were quantified in urine and liver using gas chromatography-mass spectrometry. Serum levels of aspartate aminotransferase, alanine aminotransferase, and α-glutathione S-transferase (α-GST) were also determined to measure the level of hepatotoxicity. The serum α-GST level increased slightly at the 20 mg/kg dose, and substantially increased at the 100 and 500 mg/kg dose; aspartate aminotransferase and alanine aminotransferase levels did not change with the administration of increasing doses of VPA. The liver concentration of free 4-ene VPA and the urinary excretion of total 4-ene VPA were the only measures that correlated with the increase in the serum α-GST level (p < 0.094 and p < 0.023 respectively). From these results, we conclude that hepatotoxicity of VPA correlates with liver concentration of 4-ene VPA and can be predicted by the urinary excretion of total 4-ene VPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beckett, G. J. and Hayes, J. D., Glutathione S-transferases: biomedical applications. Adv. Clin. Chem., 30, 281–380 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Bryant, A. E. and Dreifuss, F. E., Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology, 46, 465–469 (1996).

    PubMed  Google Scholar 

  • Dickinson, R. G., Harland, R. C., Ilias, A. M., Rodgers, R. N., Kaufman, S. N., Lynn, R. K., and Gerber, N., Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. J. Pharmacol. Exp. Ther., 11, 583–595 (1979).

    Google Scholar 

  • Dickinson, R. G., Hooper, W. D., Dunstan, P. R., and Eadic, M. J., Urinary excretion of valproate and some metabolites in chronically treated patients. Ther. Drug Monit., 11, 127–133 (1989).

    PubMed  CAS  Google Scholar 

  • Gopaul, S. V., Mutlib, A., and Farrell, K., Identification and characterization of N-acetylcystein conjugates of valproic acid in patients on valproic acid therapy. Drug Metab. Dispos., 28, 823–832 (2000).

    PubMed  CAS  Google Scholar 

  • Granneman, G. R., Wang, S. I., Kesterson, J. W., and Machihist, J. M., The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology, 4, 1153–8 (1984a).

    Article  PubMed  CAS  Google Scholar 

  • Granneman, G. R., Wang, S. I., Machinist, J. M., and Kesterson, J. W., Aspects of the metabolism of valproic acid. Xenobiotica, 14, 375–387 (1984b).

    Article  PubMed  CAS  Google Scholar 

  • Hergüner, M. O., Altunbaþak, S., Dogan, A., Yildizdas, D., Incecik, F., Erdogan, S., Gönlüsen, G., Daglioglu, K., Dikmen, N., and Burgut, R., Effects of sodium valproate on renal functions in rats. Ren. Fail., 28, 593–597 (2006)

    Article  PubMed  CAS  Google Scholar 

  • Kassahun, K., Farrell, K., and Abbott, F. S., Identification and characterization of the glutathione and N-acetyl conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid in rats and humans. Drug Metab. Dispos., 19, 525–535 (1991).

    PubMed  CAS  Google Scholar 

  • Korkmazer, N., Vurucu, S., Demirkaya, E., Unay, B., Kul, M., Akin, R., and Gokcay, E., Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev., 28, 515–20 (2006)

    Article  PubMed  Google Scholar 

  • Koo, D. J., Zhou, M., Claudry, I. H., and Wang, P., Plasma α-glutathione S-transferase, A sensitive Indicator of hepatocellular damage during polymicrobial sepsis, Arch. Surg., 135, 198–203 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Loguercio, C., Tuccillo, C., Caporaso, N., Del Vecchio Blanco, G., Morisco, F., Guerriero, C., Di Santolo, S. S., Valenza, L. M., and Del Vecchio Blanco, C., Determination of plasma alpha-glutathione S-transferases in patients with HCV-related chronic infection: its significance and possible clinical relevance. Liver, 18, 166–172 (1998).

    PubMed  CAS  Google Scholar 

  • Loscher, W., Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol., 58, 31–59 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Murakami, K., Sugimoto, T., Nishida, N., Kobayashi, Y., Kuhara, T., and Matsumoto, I., Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy. Brain Dev., 14, 178–181 (1992).

    PubMed  CAS  Google Scholar 

  • Nau, H. and Wittfoht, W., Valproic acid and several metabolites: Quantitative determination in serum urine, breast milk and tissues by gas chromatography-mass spectrometry using selected ion monitoring. J. Chromatogr., 226, 69–78 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Perucca, E., Pharmacological and therapeutic properties of valproate. A summary after 35 years of clinical experience. CNS Drugs, 16, 695–714 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Ray, D. C., Robbins, A. G., Howie, A. F., and Beckett, G. J., Drummond, G. B., Effect of spinal anaesthesia on plasma concentrations of glutathione S-transferase. Br. J. Anaesth., 88, 285–287 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Rettenmeier, A. W., Gordon, W. P., Prickett, K. S., Levy, R. H., and Baillie, T. A., Biotransformation and pharmacokinetic in the rhesus monkey of 2-n-propyl-4-pentanoic acid, a toxic metabolite of valproic acid. Drug Metab. Dispos. 14, 454–464 (1986).

    PubMed  CAS  Google Scholar 

  • Rettenmeier, A. W., Prickett, K. S., Gordon, W. P., Bjorge, S. M., Chang, S. L., Levy, R. H., and Baillie, T. A., Studies on the biotransformation in the perfused rat liver of 2-npropyl-4-pentanoic acid, a metabolite of antiepileptic drug valproic acid. Drug Metab. Dispos., 13, 81–96 (1985).

    PubMed  CAS  Google Scholar 

  • Seimes, H., Nau, H., and Schultz, K., Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia, 34, 332–346 (1993).

    Article  Google Scholar 

  • Sugimoto, T., Nishida, N., Yasuhara, A., Ono, A., Sakane, Y., and Matsumura, T., Reye-like syndrome associated with valproic acid. Brain Dev., 5, 334–337 (1983).

    PubMed  CAS  Google Scholar 

  • Tong, V., Teng, X. W., Chang, T. K., and Abott, F. S., Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione depleted rat hepatocytes. Toxicol. Sci., 86, 436–443 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Wang, P., Ba, Z. F., Tait, S. M., Zhou, M., Chaudry, I. H., Alterations in circulation blood volume during poly-microbial sepsis. Circ. Shock, 40, 92–98 (1993).

    PubMed  CAS  Google Scholar 

  • Yu, H. Y. and Shin, M. C., Determination of valproic acid in human plasma by capillary gas chromatography. Therp. Drug Monit., 18, 107–108 (1996).

    CAS  Google Scholar 

  • Zafrani, E. S. and Berthelot, P., Sodium valproate in the induction of unusual hepatotoxicity. Hepatology, 2, 648–649 (1982).

    PubMed  CAS  Google Scholar 

  • Zimmerman, H. J. and Ishak, K. G., Valproate-induced hepatic injury: Analysis of 23 fatal cases. Hepatology, 2, 591–597 (1982).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Byung Hwa Jung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, M.S., Lee, YJ., Kim, B.J. et al. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid. Arch. Pharm. Res. 32, 1029–1035 (2009). https://doi.org/10.1007/s12272-009-1708-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-009-1708-x

Key words

Navigation